PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Biosimilars and FDA Talk at 4th Protein Therapeutics Conference October 19-21 - Carol A. Pratt, Ph.D. and Janet M. McNicholas, Ph.D. of K&L Gates to give a featured presentation entitled “Biosimilars: Coordinating FDA and Patent Strategies” at GTC’s 4th Protein Discovery & Therapeutics Conference on Oct 19-21 in San Diego
Biosimilars and FDA Talk at 4th Protein Therapeutics Conference October 19-21

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2011/08/25 - Carol A. Pratt, Ph.D. and Janet M. McNicholas, Ph.D. of K&L Gates to give a featured presentation entitled “Biosimilars: Coordinating FDA and Patent Strategies” at GTC’s 4th Protein Discovery & Therapeutics Conference on Oct 19-21 in San Diego.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr’s Pratt and McNicholas will discuss strategies for patenting biosimilars in conjunction with FDA regulations and how to overcome the challenges of FDA approval.

Dr. Pratt provides strategic advice regarding FDA requirements to manufacturers, distributors, importers and exporters of a wide range of medical and health products, including medical devices, drugs, dietary supplements, nutraceuticals, biologics and cosmetics. In her FDA practice, she advises clients on requirements for marketing clearance or approval, registration and listing, labeling and advertising, imports and exports, Good Clinical Practice, Good Laboratory Practice, and use of investigational drugs and devices.

Dr. McNicholas advises clients in the development and commercialization of worldwide patent portfolios. She writes and prosecutes patent applications for a broad range of life science technologies. Her practice includes conducting patentability and freedom-to-operate assessments, evaluating intellectual property, and mining both developing and mature patent portfolios for additional patenting opportunities to maximize value.

Other topics to be discussed at the conference include bi-specific and multi-specific fusion proteins, modified proteins, antibody drug conjugates, patenting strategies, non-IG scaffolds, antibody fragments, new peptide approaches, nutraceuticals, advances in expression systems, immunogenicity, aggregation, subvisible particles, stability and delivery of proteins.

Also presenting at the 4th Protein Discovery & Therapeutics Conference are organizations active in the field including Affibody, Affimed, Albany Medical College, Ambrx, Anaptysbio, Centyrex, ImmunGene, Johnson & Johnson, MacroGenics, MedImmune, Merus, Micromet AG, NCI, NIH, Nektar Therapeutics, Novartis, NovImmune SA, Pfizer, Profectus BioSciences, RC Technologies, Roche, Scripps Research Institute, Zyngenia and other experts in protein therapeutics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Biosimilars and FDA Talk at 4th Protein Therapeutics Conference October 19-21

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)